Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

Related Keywords

Stockholm ,Sweden ,Pia Baumann ,Magnus Christensen , ,Nasdaq Stockholm ,European Association ,Liver Cancer Summit ,Karin Tunblad Phd ,Project Director ,Chief Medical Officer ,Small Cap ,European Journal ,Medivir ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,